Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
Strata Oncology Announces Addition of Gilead as Strata PATH Trial Collaborator
Strata Oncology, a next-generation precision oncology company enabling smarter and earlier cancer treatment, has today […]
Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs
Immunovia, the diagnostics company that has launched the world’s first blood test dedicated to the […]
OncoK9 Liquid Biopsy Test Can Enhance Cancer Monitoring in Dogs, New Results Show
PetDx, The Liquid Biopsy Company for Pets™, has released a white paper demonstrating that OncoK9®, […]
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China
CARsgen Therapeutics, a company focused on innovative CAR T-cell therapies for the treatment of hematologic […]
Theragent Secures Novel Stem Cell Bank Production Contract with Accelerated Biosciences
Theragent, a cell therapy Contract Development and Manufacturing Organization (CDMO) focused on advancing next-generation cancer […]
Neutron Therapeutics Announces Successful Generation of a Neutron Beam for BNCT at Shonan Kamakura General Hospital in Japan
Neutron Therapeutics (NT), a targeted radiation oncology therapy company developing a comprehensive clinical solution for […]
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators
AbbVie and Anima Biotech (Anima) today announced a collaboration to discover and develop mRNA biology modulators […]
Prokarium and Ginkgo Bioworks Announce Partnership to Discover Multiple Targets for RNA Therapeutics and Immuno-oncology
Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, and Ginkgo Bioworks, which […]
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Boehringer Ingelheim and 3T Biosciences today announced they have entered into a strategic collaboration and licensing […]
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
AbbVie and Immunome, a clinical-stage biopharmaceutical company that utilizes its human memory B cell platform […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more